Literature DB >> 26311426

Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer's Disease.

Heather M Wilkins, Russell H Swerdlow1.   

Abstract

Mitochondrial dysfunction and neuroinflammation occur in Alzheimer's disease (AD). The causes of these pathologic lesions remain uncertain, but links between these phenomena are increasingly recognized. In this review, we discuss data that indicate mitochondria or mitochondrial components may contribute to neuroinflammation. While mitochondrial dysfunction could cause neuroinflammation, neuroinflammation could also cause mitochondrial dysfunction. However, based on the systemic nature of AD mitochondrial dysfunction as well as data from experiments we discuss, the former possibility is perhaps more likely. If correct, then manipulation of mitochondria, either directly or through manipulations of bioenergetic pathways, could prove effective in reducing metabolic dysfunction and neuroinflammation in AD patients. We also review some potential approaches through which such manipulations may be achieved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26311426      PMCID: PMC5480219          DOI: 10.2174/1568026615666150827095102

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  81 in total

1.  Exercise enhances learning and hippocampal neurogenesis in aged mice.

Authors:  Henriette van Praag; Tiffany Shubert; Chunmei Zhao; Fred H Gage
Journal:  J Neurosci       Date:  2005-09-21       Impact factor: 6.167

Review 2.  Mechanisms of exercise-induced mitochondrial biogenesis in skeletal muscle.

Authors:  David A Hood
Journal:  Appl Physiol Nutr Metab       Date:  2009-06       Impact factor: 2.665

3.  A role for mitochondria in NLRP3 inflammasome activation.

Authors:  Rongbin Zhou; Amir S Yazdi; Philippe Menu; Jürg Tschopp
Journal:  Nature       Date:  2010-12-01       Impact factor: 49.962

4.  Endogenous oxidative stress in sporadic Alzheimer's disease neuronal cybrids reduces viability by increasing apoptosis through pro-death signaling pathways and is mimicked by oxidant exposure of control cybrids.

Authors:  Isaac G Onyango; James P Bennett; Jeremy B Tuttle
Journal:  Neurobiol Dis       Date:  2005 Jun-Jul       Impact factor: 5.996

Review 5.  Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-09-15       Impact factor: 8.401

6.  Histone deacetylases enzyme, copper, and IL-8 levels in patients with Alzheimer's disease.

Authors:  Mohamad A Alsadany; Hanan H Shehata; Magda I Mohamad; Riham G Mahfouz
Journal:  Am J Alzheimers Dis Other Demen       Date:  2012-12-12       Impact factor: 2.035

7.  Monocyte activation by necrotic cells is promoted by mitochondrial proteins and formyl peptide receptors.

Authors:  Elliott D Crouser; Guohong Shao; Mark W Julian; Jennifer E Macre; Gerald S Shadel; Susheela Tridandapani; Qin Huang; Mark D Wewers
Journal:  Crit Care Med       Date:  2009-06       Impact factor: 7.598

8.  Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity.

Authors:  Sandra M Cardoso; Isabel Santana; Russell H Swerdlow; Catarina R Oliveira
Journal:  J Neurochem       Date:  2004-06       Impact factor: 5.372

Review 9.  Exercise: a behavioral intervention to enhance brain health and plasticity.

Authors:  Carl W Cotman; Nicole C Berchtold
Journal:  Trends Neurosci       Date:  2002-06       Impact factor: 13.837

10.  Oxaloacetate supplementation increases lifespan in Caenorhabditis elegans through an AMPK/FOXO-dependent pathway.

Authors:  David S Williams; Alan Cash; Lara Hamadani; Tanja Diemer
Journal:  Aging Cell       Date:  2009-09-30       Impact factor: 9.304

View more
  36 in total

1.  The effects of exercise on hippocampal inflammatory cytokine levels, brain oxidative stress markers and memory impairments induced by lipopolysaccharide in rats.

Authors:  Zahra Jahangiri; Zahra Gholamnezhad; Mahmoud Hosseini
Journal:  Metab Brain Dis       Date:  2019-04-01       Impact factor: 3.584

Review 2.  Interaction of Cannabis Use and Aging: From Molecule to Mind.

Authors:  Hye Bin Yoo; Jennifer DiMuzio; Francesca M Filbey
Journal:  J Dual Diagn       Date:  2019-09-30

Review 3.  Small molecules as therapeutic drugs for Alzheimer's disease.

Authors:  Darryll M A Oliver; P Hemachandra Reddy
Journal:  Mol Cell Neurosci       Date:  2019-03-12       Impact factor: 4.314

Review 4.  Utilization of the CRISPR-Cas9 Gene Editing System to Dissect Neuroinflammatory and Neuropharmacological Mechanisms in Parkinson's Disease.

Authors:  Jie Luo; Piyush Padhi; Huajun Jin; Vellareddy Anantharam; Gary Zenitsky; Qian Wang; Auriel A Willette; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  J Neuroimmune Pharmacol       Date:  2019-03-16       Impact factor: 4.147

Review 5.  Insulin resistance: a connecting link between Alzheimer's disease and metabolic disorder.

Authors:  Viplav Kshirsagar; Chetan Thingore; Archana Juvekar
Journal:  Metab Brain Dis       Date:  2020-09-28       Impact factor: 3.584

Review 6.  Carnosic Acid as a Promising Agent in Protecting Mitochondria of Brain Cells.

Authors:  Marcos Roberto de Oliveira
Journal:  Mol Neurobiol       Date:  2018-01-15       Impact factor: 5.590

7.  Prophylaxis of mitochondrial dysfunction caused by cellular decompression from hyperbaric exposure.

Authors:  Abhay Ranganathan; Shawn Owiredu; David H Jang; David M Eckmann
Journal:  Mitochondrion       Date:  2020-02-08       Impact factor: 4.160

8.  Oxaloacetate enhances neuronal cell bioenergetic fluxes and infrastructure.

Authors:  Heather M Wilkins; Scott Koppel; Steven M Carl; Suruchi Ramanujan; Ian Weidling; Mary L Michaelis; Elias K Michaelis; Russell H Swerdlow
Journal:  J Neurochem       Date:  2016-03-11       Impact factor: 5.372

9.  Microdose Lithium Treatment Reduced Inflammatory Factors and Neurodegeneration in Organotypic Hippocampal Culture of Old SAMP-8 Mice.

Authors:  Mariana Toricelli; Sebastiana Ribeiro Evangelista; Hudson Sousa Buck; Tania Araujo Viel
Journal:  Cell Mol Neurobiol       Date:  2020-07-08       Impact factor: 5.046

10.  Tranilast, a Transient Receptor Potential Vanilloid 2 Channel (TRPV2) Inhibitor Attenuates Amyloid β-Induced Cognitive Impairment: Possible Mechanisms.

Authors:  Pavan Thapak; Mahendra Bishnoi; Shyam Sunder Sharma
Journal:  Neuromolecular Med       Date:  2021-07-06       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.